Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non‐associative immune‐mediated thrombocytopenia: 20 cases (2008‐2021)

Documenti analoghi

• Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia
  di: E. Stikeman, et al.
  Pubblicazione: (2024)
• Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021)
  di: C. D. Prior, et al.
  Pubblicazione: (2025)
• Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital portosystemic shunts: 363 cases (2010‐2023)
  di: M. Walton‐Clark, et al.
  Pubblicazione: (2025)
• Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011–2021)
  di: C. Prior, et al.
  Pubblicazione: (2024)
• High‐dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS‐441524 and adjunctive mefloquine: 46 cases (2023)
  di: T. Kamiyoshi, et al.
  Pubblicazione: (2025)